NIH Clinical Trial Integrity Act

# NIH Clinical Trial Integrity Act Summary **What the Bill Would Do:** The NIH Clinical Trial Integrity Act would strengthen oversight and quality standards for clinical trials funded or conducted by the National Institutes of Health (NIH). While specific provisions aren't detailed in the basic bill information available, the title suggests the legislation aims to improve the integrity, transparency, and reliability of these federally-funded medical research studies. **Who It Affects:** This bill would primarily impact the NIH and researchers conducting clinical trials with federal funding, as well as patients who participate in these studies.

It could also affect pharmaceutical companies and medical institutions that conduct NIH-funded research. **Current Status:** The bill (S 3564) was introduced in the 119th Congress by Senator Andy Kim (D-New Jersey) and is currently in committee, meaning it has not yet been voted on by the full Senate. For the most current and detailed information about specific provisions, you would need to check Congress.gov or the bill's full text.